BioDlink
BioDlink Biopharm (Stock Code: 1875.HK) is a global leading contract development and manufacturing organization (CDMO) specializing in biologics, committed to becoming the industry-leading, trusted partner of choice for biopharmaceutical clients. Leveraging our advanced one-stop integrated platform, we accelerate client project timelines by providing end-to-end CDMO services—from early R&D to commercial manufacturing for protein-based therapeutics (such as mAb, BsAb), biosimilars, and bioconjugate drugs (such as XDCs/ADCs).
